COMPASS THERAPEUTICS INC (CMPX) Stock Income Statement
NASDAQ:CMPX • US20454B1044
Current stock price
5.45 USD
+0.02 (+0.37%)
At close:
5.4 USD
-0.05 (-0.92%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 850.00K | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 72.84M | 57.48M | 50.36M | 41.66M | 81.88M | |||
| Research and Development | 55.97M | 42.34M | 38.12M | 30.00M | 70.96M | |||
| Selling, General, and Administrative Expenses | 16.87M | 15.13M | 12.24M | 11.66M | 10.93M | |||
| Operating Income | -72.84M | -56.63M | -50.36M | -41.66M | -81.88M | |||
| Interest Income/Expense | 6.35M | 7.30M | 7.87M | 2.36M | -340.00K | |||
| Other Income/Expense | N/A | -50.00K | N/A | N/A | N/A | |||
| Income Before Taxes | -66.49M | -49.38M | -42.49M | -39.23M | -82.18M | |||
| Income Tax | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | -66.49M | -49.38M | -42.49M | -39.23M | -82.18M | |||
| EBITDA | -71.37M | -56.04M | -49.66M | -40.88M | -81.31M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.42 | -0.36 | -0.33 | -0.37 | -1.31 | |||
| Non GAAP EPS | -0.43 | -0.37 | -0.34 | -0.37 | N/A | |||
| Statistics | ||||||||
| Profit Margin | N/A | -5808.82% | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | -6661.76% | N/A | N/A | N/A | |||
All data in USD